Severity, control, and responsiveness in asthma

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 3, 2006, Pages 544-548

  Stoloff, Stuart W ^a   Boushey, Homer A ^b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Assessment; Asthma severity; Control; Monitoring; Responsiveness

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID;

ASTHMA; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; GENETIC HETEROGENEITY; HUMAN; HYPERTENSION; LOW DRUG DOSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT RESPONSE;

EID: 33644773338     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.01.005     Document Type: Article

References (51)

1. M. Schatz, D. Mosen, A.J. Apter, R.S. Zeiger, W.M. Vollmer, and T.B. Stibolt Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis J Allergy Clin Immunol 115 2005 1049 1055
2. A.L. Fuhlbrigge Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers Curr Opin Pulm Med 10 2004 1 6
3. D.W. Cockcroft, and V.A. Swystun Asthma control versus asthma severity J Allergy Clin Immunol 98 1996 1016 1018
4. C.S. Cleeland, and K.M. Ryan Pain assessment: global use of the Brief Pain Inventory Ann Acad Med Singapore 23 1994 129 138
5. K.F. Rabe, M. Adachi, C.K. Lai, J.B. Soriano, P.A. Vermeire, and K.B. Weiss Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys J Allergy Clin Immunol 114 2004 40 47
6. A.L. Fuhlbrigge, R.J. Adams, T.W. Guilbert, E. Grant, P. Lozano, and S.L. Janson The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines Am J Respir Crit Care Med 166 2002 1044 1049
7. R.A. Nathan, C.A. Sorkness, M. Kosinski, M. Schatz, J.T. Li, and P. Marcus Development of the asthma control test: a survey for assessing asthma control J Allergy Clin Immunol 113 2004 59 65
8. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907
9. W.M. Vollmer, L.E. Markson, E. O'Connor, L.L. Sanocki, L. Fitterman, and M. Berger Association of asthma control with health care utilization and quality of life Am J Respir Crit Care Med 160 1999 1647 1652
10. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
11. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
12. R.A. Phillips, and J.M. Weinberg Hypertension 2005: an evidence-based approach to diagnosis and treatment - an American perspective Exp Rev Cardiovasc Ther 3 2005 691 704
13. W.O. Spitzer, S. Suissa, P. Ernst, R.I. Horwitz, B. Habbick, and D. Cockcroft The use of β-agonists and the risk of death and near death from asthma N Engl J Med 326 1992 501 506
14. J.G. Donahue, S.T. Weiss, J.M. Livingston, M.A. Goetsch, D.K. Greineder, and R. Platt Inhaled corticosteroids and the risk of hospitalization for asthma JAMA 277 1997 887 891
15. P.M. O'Byrne Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma Am J Respir Crit Care Med 172 2005 410 412
16. E.D. Bateman Measuring asthma control Curr Opin Allergy Clin Immunol 1 2001 211 216
17. S.D. Sullivan, K.B. Weiss, H. Lynn, H. Mitchell, M. Kattan, and P.J. Gergen The cost-effectiveness of an inner-city asthma intervention for children J Allergy Clin Immunol 110 2002 576 581
18. P.J. Brown, H.W. Greville, and K.E. Finucane Asthma and irreversible airflow obstruction Thorax 39 1984 131 136
19. P. Lange, J. Parner, J. Vestbo, P. Schnohr, and G. Jensen A 15-year follow-up study of ventilatory function in adults with asthma N Engl J Med 339 1998 1194 1200
20. J. Bousquet, J. Knani, H. Dhivert, A. Richard, A. Chicoye, and J.E. Ware Quality of life in asthma. Internal consistency and validity of the SF-36 questionnaire Am J Respir Crit Care Med 149 1994 371 375
21. R.J. Adams, B.J. Smith, and R.E. Ruffin Factors associated with hospital admissions and repeat emergency department visits for adults with asthma Thorax 55 2000 566 573
22. R.L. Cowie, M.F. Underwood, S.G. Revitt, and S.K. Field Predicting emergency department utilization in adults with asthma: a cohort study J Asthma 38 2001 179 184
23. Y. Belessis, S. Dixon, A. Thomsen, B. Duffy, W. Rawlinson, and R. Henry Risk factors for an intensive care unit admission in children with asthma Pediatr Pulmonol 37 2004 201 209
24. R.C. Strunk, A.L. Sternberg, L.B. Bacharier, and S.J. Szefler Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program J Allergy Clin Immunol 110 2002 395 403
25. J.G. Ayres, J.F. Miles, and P.J. Barnes Brittle asthma Thorax 53 1998 315 321
26. G.J. Rodrigo, and C. Rodrigo Rapid-onset asthma attack: a prospective cohort study about characteristics and response to emergency department treatment Chest 118 2000 1547 1552
27. R.G. Barr, P.G. Woodruff, S. Clark, and C.A. Camargo Sudden-onset asthma exacerbations: clinical features, response to therapy, and 2-week follow-up. Multicenter Airway Research Collaboration (MARC) investigators Eur Respir J 15 2000 266 273
28. S.C. Lazarus, H.A. Boushey, J.V. Fahy, V.M. Chinchilli, R.F. Lemanske, and C.A. Sorkness Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial JAMA 285 2001 2583 2593
29. A.L. Fuhlbrigge, B.T. Kitch, A.D. Paltiel, K.M. Kuntz, P.J. Neumann, and D.W. Dockery FEV(1) is associated with risk of asthma attacks in a pediatric population J Allergy Clin Immunol 107 2001 61 67
30. L. Prieto, L. Bruno, V. Gutierrez, S. Uixera, C. Perez-Frances, and A. Lanuza Airway responsiveness to adenosine 5′-monophosphate and exhaled nitric oxide measurements: predictive value as markers for reducing the dose of inhaled corticosteroids in asthmatic subjects Chest 124 2003 1325 1333
31. J.K. Sont, L.N. Willems, E.H. Bel, J.H. van Krieken, J.P. Vandenbroucke, and P.J. Sterk Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group Am J Respir Crit Care Med 159 1999 1043 1051
32. P.G. Gibson, R.L. Henry, and P. Thomas Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate Eur Respir J 16 2000 1008 1015
33. L.P. Boulet, V. Boulet, and J. Milot How should we quantify asthma control? A proposal Chest 122 2002 2217 2223
34. M.S. Harkins, K.L. Fiato, and G.K. Iwamoto Exhaled nitric oxide predicts asthma exacerbation J Asthma 41 2004 471 476
35. M.L. Bartoli, E. Bacci, S. Carnevali, S. Cianchetti, F.L. Dente, and A. Di Franco Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation Respir Med 98 2004 184 193
36. I.D. Pavord, P.J. Sterk, F.E. Hargreave, J.C. Kips, M.D. Inman, and R. Louis Clinical applications of assessment of airway inflammation using induced sputum Eur Respir J Suppl 37 2002 40s 43s
37. S.L. Jones, J. Kittelson, J.O. Cowan, E.M. Flannery, R.J. Hancox, and C.R. McLachlan The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control Am J Respir Crit Care Med 164 2001 738 743
38. P.J. Barnes Efficacy of inhaled corticosteroids in asthma J Allergy Clin Immunol 102 1998 531 538
39. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721
40. A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, and D.R. Taylor Use of exhaled nitric oxide measurements to guide treatment in chronic asthma N Engl J Med 352 2005 2163 2173
41. CAMP Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group N Engl J Med 343 2000 1054 1063
42. D.A. Stempel, and A.L. Fuhlbrigge Defining the responder in asthma therapy J Allergy Clin Immunol 115 2005 466 469
43. W.M. Vollmer Assessment of asthma control and severity Ann Allergy Asthma Immunol 93 2004 409 413 ; quiz 414-6, 492
44. O. Nishiyama, K. Kato, H. Kume, Y. Ito, R. Suzuki, and K. Yamaki Asthma health status: influence of disease severity categorized by peak expiratory flow J Asthma 40 2003 281 287
45. K.L. Timonen, J. Schwartz, J. Nielsen, and B. Brunekreef Associations between markers of respiratory morbidity in European children Eur Respir J 19 2002 479 486
46. J.D. Leuppi, C.M. Salome, C.R. Jenkins, S.D. Anderson, W. Xuan, and G.B. Marks Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids Am J Respir Crit Care Med 163 2001 406 412
47. P.A. Greenberger Allergic bronchopulmonary aspergillosis J Allergy Clin Immunol 110 2002 685 692
48. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, and R.A. Pauwels Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study Am J Respir Crit Care Med 170 2004 836 844
49. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health/National Heart, Lung, and blood Institute, National of Health; 1997.
50. Global Initiative for Asthma. Global strategy for asthma management and prevention. Bethesda (MD): National Institutes of Health/National Heart, Lung, and blood Institute, National of Health; 1998. National Institutes of Health publication no. 02.3659.
51. D.A. Stempel, T.P. McLaughin, R.H. Stanford, and A.L. Fuhlbrigge Patterns of asthma control: a 3-year analysis of patient claims J Allergy Clin Immunol 115 2005 935 939